EMUC 2014

Oncology Meeting Resources

14 Nov - 16 Nov, Lisbon, Portugal

EMUC 2014 Square

With the increased importance of multidisciplinarity and collaboration in the diagnosis and treatment of urological cancers, the European Multidisciplinary Meeting on Urological Cancers (EMUC) focuses on bringing together world-leading urologists, radiotherapy specialists, and medical oncologists to discuss the future of uro-oncological care.

Here, you will find the webcasts from EMUC 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Search Meeting Resources by Keyword

Useful links

Presenter Presentation title Session title
P-A. Abrahamsson EAU Welcome and Introduction
G. Giannarini Case presentation including voting Prostate cancer: Management of progressing disease
J. Barentsz Optimising imaging for biochemical recurrence Prostate cancer: Management of progressing disease
M. Gleave Understanding the natural history of progressing PCa: Is treatment always needed? Prostate cancer: Management of progressing disease
M. Hussain Intermittent hormonal therapy - for the worse or the better? Prostate cancer: Management of progressing disease
P-A. Abrahamsson Intermittent hormonal therapy - for the better or the worse? Prostate cancer: Management of progressing disease
M. Van Vulpen Curative radiotherapy for local recurrence: When and to whom? Prostate cancer: Management of progressing disease
S. Joniau Curative surgery for local recurrence: When and to whom? Prostate cancer: Management of progressing disease
G. Attard Optimal treatment sequencing for mCRPC: When is docetaxel (not) the first choice? Prostate cancer: Management of progressing disease
A. Horwich, S. Osanto Best of journals: Medical oncology Best of journals: Medical oncology
N. Mottet Pro - The Urologist's side Debate: Is surveillance the standard of care for all stage 1 testicular cancers?
J. Oldenburg Con - The Medical oncologist's side Debate: Is surveillance the standard of care for all stage 1 testicular cancers?
J. Bellmunt The role of checkpoint inhibitors in Uro-Oncology Translational research session: When science meets the clinic
M. Blute Defining the optimal extent of surgery: The role of lymph node dissection General session: Kidney cancer - Locally advanced
J. Brugarolas Genomics will determine the management of locally advanced RCC General session: Kidney cancer - Locally advanced